Rejunuron DN Tablet SR
Marketer
Fourrts India Laboratories Pvt Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Rejunuron DN Tablet SR
Neuropathic pain is treated with the prescription medication, Rejunuron DN Tablet SR, a sustained-release tablet. It alleviates pain by regulating calcium channel function within nerve cells. This medication also safeguards nerve fibers and facilitates the repair of damaged nerve cells. Administered orally, Rejunuron DN Tablet SR can be taken with or without food, ideally before sleep. Consistent daily timing helps maintain stable drug levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. Abrupt cessation requires prior consultation with your physician. Common side effects, generally mild and improving over time, may include nasal congestion, increased appetite, elevated mood, shaking, visual blurring, dry mouth, dizziness, and drowsiness. Avoid activities requiring concentration until the drug's effects are understood. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Always disclose all other medications you are using, as interactions can reduce Rejunuron DN Tablet SR's effectiveness or alter its action. Inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Rejunuron DN Tablet SR
Managing neuropathic pain
Major Benefits of Rejunuron DN Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Rejunuron DN Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of Rejunuron DN Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Rejunuron DN Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rejunuron DN Tablet SR can be consumed with or without food, however, consistent daily timing is recommended.
How Rejunuron DN Tablet SR works:
Rejunuron DN SR tablets contain methylcobalamin and pregabalin, working synergistically to manage neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath production, protecting and repairing nerve fibers. Pregabalin, an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Rejunuron DN Tablet SR and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Rejunuron DN Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Rejunuron DN Tablet SR while breastfeeding is likely inadvisable. Preliminary human studies indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rejunuron DN Tablet SR might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Rejunuron DN Tablet SR. A modified dosage of Rejunuron DN Tablet SR might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Rejunuron DN Tablet SR appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary for this patient population. Physician consultation is recommended.
What if you forget to take Rejunuron DN Tablet SR :
Should you forget a Rejunuron DN Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Rejunuron DN Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |






